RBFOX3 and Alzheimer disease: In contrast, there was no difference in SNV/mb burden between PU.1+, NEUN+, and DN samples from AD patients and age-matched controls (Figure 2B), and between PU.1+ nuclei from the cortex, hippocampus, and brainstem/cerebellum samples (Figure 2C).